SALT LAKE CITY, UT--(Marketwire - November 27, 2007) - Myriad Genetics, Inc. (NASDAQ: MYGN) announced today that it has elected Gerald P. (Jerry) Belle to its board of directors. Mr. Belle's term is effective as of November 15, 2007.
Mr. Belle was previously President and CEO, North American Pharmaceuticals, Aventis, Inc., until his retirement from the Company in 2004, after more than 26 years of service, the majority of which was in executive commercial and general management positions in Asia, Europe/Middle East/Africa and Canada. Following retirement from Aventis, he was appointed Executive Chairman of Merial, Ltd., a global leader in animal health and a joint venture between Merck and sanofi-aventis.
